Related Experiment Video

Updated: May 31, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Vaccine-based clinical trials in ovarian cancer

Ninke Leffers1, Toos Daemen, H Marike Boezen

  • 1Department of Gynaecologic Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Expert Review of Vaccines
|June 23, 2011
PubMed

Insights

Ovarian cancer vaccines show promise in early trials, inducing immune responses but not always clinical benefit. Multimodal therapy combining surgery, chemotherapy, and immunotherapy is crucial for effective ovarian cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Vaccines

Background:

  • Epithelial ovarian cancer treatment is evolving.
  • Ovarian cancer vaccines represent a novel therapeutic avenue.

Purpose of the Study:

  • To review current ovarian cancer vaccine strategies.
  • To identify challenges in vaccine study design and efficacy.
  • To propose solutions for enhancing clinical outcomes.

Main Methods:

  • Review of existing literature on ovarian cancer immunization strategies.
  • Analysis of Phase I/II clinical trial data.
  • Discussion of potential pitfalls and solutions in study design.

Main Results:

  • Antigen-specific immunization elicits immune responses but clinical benefit is inconsistent.
  • Most ovarian cancer vaccines are in early-stage (Phase I/II) trials.
  • Efficacy evaluation is limited in current studies.

Conclusions:

  • Ovarian cancer vaccines require further development and optimization.
  • Multimodal treatment is essential, integrating surgery, chemotherapy, immunotherapy, and targeted therapy.
  • Future research should focus on improving vaccine design and clinical trial methodology.

More Related Videos

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing05:35

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing

Published on: September 15, 2023

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...